Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CURIS-INC-43565027/news/Curis-Enters-into-Agreement-for-Emavusertib-Pembrolizumab-Combination-Study-in-Melanoma-45503199/?utm_source=whatsapp&utm_medium=social&utm_campaign=share